Clinical trials: Intestinal FDG Uptake
Intestinal FDG Uptake
A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
Patients who undergo PET-CT scans to look for cancer are given an intravenous contrast (FDG) that is taken-up by active cells such as cancer cells. This contrast can then be seen in the body using the PET-CT scanner.
- Trial name
- NCT01542541
- Testing
- Rifaximin
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Beth Israel Deaconess Medical Center